Drug Type Small molecule drug |
Synonyms PF 6459988, PF-6459988 |
Target |
Action inhibitors |
Mechanism EGFR T790M inhibitors(Epidermal Growth Factor Receptor T790M inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H22ClN7O3 |
InChIKeyODMXWZROLKITMS-RISCZKNCSA-N |
CAS Registry1428774-45-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
EGFR-mutated non-small Cell Lung Cancer | Phase 2 | - | 01 Jan 2015 |